Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

NXRT vs IRT vs NVCR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
NXRT
NexPoint Residential Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$748M
5Y Perf.-7.8%
IRT
Independence Realty Trust, Inc.

REIT - Residential

Real EstateNYSE • US
Market Cap$3.89B
5Y Perf.+66.8%
NVCR
NovoCure Limited

Medical - Instruments & Supplies

HealthcareNASDAQ • JE
Market Cap$1.81B
5Y Perf.-76.4%

NXRT vs IRT vs NVCR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
NXRT logoNXRT
IRT logoIRT
NVCR logoNVCR
IndustryREIT - ResidentialREIT - ResidentialMedical - Instruments & Supplies
Market Cap$748M$3.89B$1.81B
Revenue (TTM)$252M$662M$674M
Net Income (TTM)$-32M$48M$-173M
Gross Margin91.1%20.2%75.2%
Operating Margin11.5%17.5%-27.2%
Forward P/E100.7x
Total Debt$1.56B$2.28B$290M
Cash & Equiv.$14M$48M$103M

NXRT vs IRT vs NVCRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

NXRT
IRT
NVCR
StockMay 20May 26Return
NexPoint Residentia… (NXRT)10092.2-7.8%
Independence Realty… (IRT)100166.8+66.8%
NovoCure Limited (NVCR)10023.6-76.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: NXRT vs IRT vs NVCR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IRT leads in 3 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. NexPoint Residential Trust, Inc. is the stronger pick specifically for valuation and capital efficiency and dividend income and shareholder returns. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
NXRT
NexPoint Residential Trust, Inc.
The Real Estate Income Play

NXRT is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 0.62, yield 7.2%
  • 216.0% 10Y total return vs IRT's 202.0%
  • Beta 0.62, yield 7.2%, current ratio 0.48x
Best for: income & stability and long-term compounding
IRT
Independence Realty Trust, Inc.
The Real Estate Income Play

IRT has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.

  • Lower volatility, beta 0.48, Low D/E 63.6%, current ratio 0.05x
  • 7.3% margin vs NVCR's -25.7%
  • Beta 0.48 vs NVCR's 2.20, lower leverage
Best for: sleep-well-at-night
NVCR
NovoCure Limited
The Growth Play

NVCR is the clearest fit if your priority is growth exposure.

  • Rev growth 8.3%, EPS growth 21.8%, 3Y rev CAGR 6.8%
  • 8.3% revenue growth vs NXRT's -3.2%
  • -10.6% vs NXRT's -17.3%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthNVCR logoNVCR8.3% revenue growth vs NXRT's -3.2%
ValueNXRT logoNXRTBetter valuation composite
Quality / MarginsIRT logoIRT7.3% margin vs NVCR's -25.7%
Stability / SafetyIRT logoIRTBeta 0.48 vs NVCR's 2.20, lower leverage
DividendsNXRT logoNXRT7.2% yield, 12-year raise streak, vs IRT's 4.0%, (1 stock pays no dividend)
Momentum (1Y)NVCR logoNVCR-10.6% vs NXRT's -17.3%
Efficiency (ROA)IRT logoIRT0.8% ROA vs NVCR's -16.5%, ROIC 1.6% vs -16.4%

NXRT vs IRT vs NVCR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NXRTNexPoint Residential Trust, Inc.

Segment breakdown not available.

IRTIndependence Realty Trust, Inc.
FY 2018
Real Estate Other
67.6%$14M
Tenant Reimbursement Income
32.4%$7M
NVCRNovoCure Limited

Segment breakdown not available.

NXRT vs IRT vs NVCR — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLIRTLAGGINGNVCR

Income & Cash Flow (Last 12 Months)

NXRT leads this category, winning 3 of 6 comparable metrics.

NVCR is the larger business by revenue, generating $674M annually — 2.7x NXRT's $252M. IRT is the more profitable business, keeping 7.3% of every revenue dollar as net income compared to NVCR's -25.7%. On growth, NVCR holds the edge at +12.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
RevenueTrailing 12 months$252M$662M$674M
EBITDAEarnings before interest/tax$125M$365M-$165M
Net IncomeAfter-tax profit-$32M$48M-$173M
Free Cash FlowCash after capex$79M$139M-$48M
Gross MarginGross profit ÷ Revenue+91.1%+20.2%+75.2%
Operating MarginEBIT ÷ Revenue+11.5%+17.5%-27.2%
Net MarginNet income ÷ Revenue-12.7%+7.3%-25.7%
FCF MarginFCF ÷ Revenue+31.2%+21.1%-7.1%
Rev. Growth (YoY)Latest quarter vs prior year+0.5%+2.5%+12.3%
EPS Growth (YoY)Latest quarter vs prior year0.0%-101.4%-100.0%
NXRT leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — NXRT and IRT each lead in 2 of 5 comparable metrics.

On an enterprise value basis, IRT's 16.8x EV/EBITDA is more attractive than NXRT's 18.5x.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
Market CapShares × price$748M$3.9B$1.8B
Enterprise ValueMkt cap + debt − cash$2.3B$6.1B$2.0B
Trailing P/EPrice ÷ TTM EPS-23.40x68.75x-13.02x
Forward P/EPrice ÷ next-FY EPS est.100.67x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple18.53x16.80x
Price / SalesMarket cap ÷ Revenue2.98x5.91x2.76x
Price / BookPrice ÷ Book value/share2.49x1.08x5.20x
Price / FCFMarket cap ÷ FCF8.95x26.54x
Evenly matched — NXRT and IRT each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

IRT leads this category, winning 7 of 9 comparable metrics.

IRT delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-51 for NVCR. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), IRT scores 6/9 vs NXRT's 4/9, reflecting solid financial health.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
ROE (TTM)Return on equity-10.1%+1.3%-50.8%
ROA (TTM)Return on assets-1.7%+0.8%-16.5%
ROICReturn on invested capital+1.1%+1.6%-16.4%
ROCEReturn on capital employed+1.5%+2.4%-28.9%
Piotroski ScoreFundamental quality 0–9465
Debt / EquityFinancial leverage5.18x0.64x0.85x
Net DebtTotal debt minus cash$1.5B$2.2B$187M
Cash & Equiv.Liquid assets$14M$48M$103M
Total DebtShort + long-term debt$1.6B$2.3B$290M
Interest CoverageEBIT ÷ Interest expense0.47x1.73x-96.80x
IRT leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

IRT leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in IRT five years ago would be worth $12,187 today (with dividends reinvested), compared to $787 for NVCR. Over the past 12 months, NVCR leads with a -10.6% total return vs NXRT's -17.3%. The 3-year compound annual growth rate (CAGR) favors IRT at 2.9% vs NVCR's -38.5% — a key indicator of consistent wealth creation.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
YTD ReturnYear-to-date+1.5%-5.3%+21.0%
1-Year ReturnPast 12 months-17.3%-11.9%-10.6%
3-Year ReturnCumulative with dividends-17.1%+9.0%-76.7%
5-Year ReturnCumulative with dividends-20.9%+21.9%-92.1%
10-Year ReturnCumulative with dividends+216.0%+202.0%+40.0%
CAGR (3Y)Annualised 3-year return-6.1%+2.9%-38.5%
IRT leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

IRT leads this category, winning 2 of 2 comparable metrics.

IRT is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than NVCR's 2.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IRT currently trades 83.7% from its 52-week high vs NXRT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
Beta (5Y)Sensitivity to S&P 5000.62x0.48x2.20x
52-Week HighHighest price in past year$38.64$19.71$20.06
52-Week LowLowest price in past year$23.79$14.60$9.82
% of 52W HighCurrent price vs 52-week peak+76.3%+83.7%+79.2%
RSI (14)Momentum oscillator 0–10067.664.376.7
Avg Volume (50D)Average daily shares traded222K2.3M1.6M
IRT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

NXRT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: NXRT as "Hold", IRT as "Buy", NVCR as "Buy". Consensus price targets imply 111.0% upside for NVCR (target: $34) vs -8.4% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.15% vs IRT's 3.99%.

MetricNXRT logoNXRTNexPoint Resident…IRT logoIRTIndependence Real…NVCR logoNVCRNovoCure Limited
Analyst RatingConsensus buy/hold/sellHoldBuyBuy
Price TargetConsensus 12-month target$27.00$20.08$33.50
# AnalystsCovering analysts102715
Dividend YieldAnnual dividend ÷ price+7.2%+4.0%
Dividend StreakConsecutive years of raises124
Dividend / ShareAnnual DPS$2.11$0.66
Buyback YieldShare repurchases ÷ mkt cap+1.0%+0.8%0.0%
NXRT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

IRT leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). NXRT leads in 2 (Income & Cash Flow, Analyst Outlook). 1 tied.

Best OverallIndependence Realty Trust, … (IRT)Leads 3 of 6 categories
Loading custom metrics...

NXRT vs IRT vs NVCR: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is NXRT or IRT or NVCR a better buy right now?

For growth investors, NovoCure Limited (NVCR) is the stronger pick with 8.

3% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). Independence Realty Trust, Inc. (IRT) offers the better valuation at 68. 8x trailing P/E (100. 7x forward), making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — NXRT or IRT or NVCR?

Over the past 5 years, Independence Realty Trust, Inc.

(IRT) delivered a total return of +21. 9%, compared to -92. 1% for NovoCure Limited (NVCR). Over 10 years, the gap is even starker: NXRT returned +216. 0% versus NVCR's +40. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — NXRT or IRT or NVCR?

By beta (market sensitivity over 5 years), Independence Realty Trust, Inc.

(IRT) is the lower-risk stock at 0. 48β versus NovoCure Limited's 2. 20β — meaning NVCR is approximately 356% more volatile than IRT relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — NXRT or IRT or NVCR?

By revenue growth (latest reported year), NovoCure Limited (NVCR) is pulling ahead at 8.

3% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Independence Realty Trust, Inc. grew EPS 41. 2% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, NVCR leads at 6. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — NXRT or IRT or NVCR?

Independence Realty Trust, Inc.

(IRT) is the more profitable company, earning 8. 6% net margin versus -20. 8% for NovoCure Limited — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRT leads at 18. 4% versus -23. 5% for NVCR. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is NXRT or IRT or NVCR more undervalued right now?

Analyst consensus price targets imply the most upside for NVCR: 111.

0% to $33. 50.

07

Which pays a better dividend — NXRT or IRT or NVCR?

In this comparison, NXRT (7.

2% yield), IRT (4. 0% yield) pay a dividend. NVCR does not pay a meaningful dividend and should not be held primarily for income.

08

Is NXRT or IRT or NVCR better for a retirement portfolio?

For long-horizon retirement investors, Independence Realty Trust, Inc.

(IRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 4. 0% yield, +202. 0% 10Y return). NovoCure Limited (NVCR) carries a higher beta of 2. 20 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IRT: +202. 0%, NVCR: +40. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between NXRT and IRT and NVCR?

These companies operate in different sectors (NXRT (Real Estate) and IRT (Real Estate) and NVCR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NXRT is a small-cap income-oriented stock; IRT is a small-cap income-oriented stock; NVCR is a small-cap quality compounder stock. NXRT, IRT pay a dividend while NVCR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

NXRT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 54%
  • Dividend Yield > 2.8%
Run This Screen
Stocks Like

IRT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 1.5%
Run This Screen
Stocks Like

NVCR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 45%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform NXRT and IRT and NVCR on the metrics below

Revenue Growth>
%
(NXRT: 0.5% · IRT: 2.5%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.